ENTITY
Shanghai Fudan Zhangjiang H

Shanghai Fudan Zhangjiang H (1349 HK)

49
Analysis
Health CareChina
Shanghai Fudan-Zhangjiang Bio-pharmaceutical Company Limited researches, develops, and sells self-developed bio-pharmaceutical know-how. The Company also carries out contracted research for customers, manufactures and sells diagnostic reagent, and provides related ancillary services in China.
more
Refresh
01 Oct 2023 10:10

A-H Premium Weekly (Sep 29th): Beigene, China Vanke, Guangzhou Automobile, Wuapptec, Byd

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Beigene, China Vanke, Guangzhou Automobile, Wuapptec, Byd.

Logo
498 Views
Share
10 Sep 2023 10:10

A-H Premium Weekly (Sep 8th): Huadian Power, Huaneng Power, Shanghai Electric, China Longyuan

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Huadian Power, Huaneng Power, Shanghai Electric, China...

Logo
435 Views
Share
06 Sep 2023 12:34

Hong Kong Connect Flows (August): $8.8bn Outflows

We analyzed the Hong Kong Connect Scheme for the month of August and highlight flows for Meituan, CCB, China Mobile, CNOOC, HKEX.

Logo
347 Views
Share
30 Jul 2023 10:10

A-H Premium Weekly (Jul 28th): China Vanke, CITIC Sec, China Pacific, BYD, CMOC, GF Sec, CICC

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Vanke, CITIC Sec, China Pacific, BYD, CMOC, GF Sec, CICC.

Logo
326 Views
Share
25 Jun 2023 10:05

A-H Premium Weekly (Jun 23rd): BYD, CMOC, China Southern, Cansino Biologics, Xinjiang Gold

We analyzed A-H premium changes in the past week and highlight A-H premium changes for  BYD, CMOC, China Southern, Cansino Biologics, Xinjiang Gold.

Logo
469 Views
Share
x